We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





College of American Pathologists Releases New Proficiency Testing Program for Detection of SARS CoV-2

By LabMedica International staff writers
Posted on 11 Apr 2020
Print article
Illustration
Illustration
The College of American Pathologists {(CAP) Northfield, IL, USA) has responded to the global coronavirus disease (COVID-19) pandemic by releasing a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PT is used to gauge the performance of individual laboratories for specific tests and monitors continuing performance while comparing performance with other laboratories.

The CAP is an organization of board-certified pathologists and a leading provider of laboratory accreditation and proficiency testing programs that serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP offers the most comprehensive PT programs that CAP members, along with other scientists, scientifically develop and validate. More than 22,000 laboratories across the world are enrolled in the CAP’s PT programs.

The Microbiology Committee members piloted the new program with a set of laboratories prior to making it available, allowing committee members and CAP staff to verify specimen performance across the multiple methods and testing platforms. Specifically, the program is for the detection of SARS-CoV-2 by nucleic acid amplification testing. Further, it provides samples that are non-infectious and target consensus gene regions N, E, RdRp, S, and ORF1a, as well as allows laboratories to assess their entire workflow from nucleic acid extraction through detection.

“In the midst of the enormous pressure laboratories are facing, along with everyone working in health care during the COVID-19 crisis, laboratories are seeking to measure their performance when testing for the disease,” said Raouf Nakhleh, MD, FCAP, chair of the CAP’s Council on Scientific Affairs. “The CAP’s Microbiology Committee quickly came together to develop this high-quality program.”

Related Links:
College of American Pathologists

Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Liquid Based Cytology Production Machine
LBP-4032
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.